Who We Are
Who we are:
- Amethyst Radiotherapy Group is Europe’s fastest growing private healthcare provider of cancer therapies. Our focus is on radiation oncology.
- Our parent company, Amethyst Top BV, together with its wholly owned subsidiary Amethyst Radiotherapy Group BV, is based in the Netherlands.
- The Amethyst Radiotherapy Group was established in 2012.
- The Amethyst’s philosophy:
- Our corporate goals are ambitious, but our patients are always at the centre of our attention.
- Optimised processes and an interdisciplinary treatment and care model guarantee outstanding quality and efficiency.
- We ensure that all patients at our facilities are always treated medically and technically at the highest level and in accordance with the latest international standards.
- Amethyst ensures the necessary continuous investment through its experienced and well-financed investors.
Amethysts Vision-Mission-Value statement
AMETHYST VISION
“where we want to go”
We want to be the lucky stone, the “amulet” of cancer patients throughout Europe in their long battle against cancer
AMETHYST MISSION
“what we are here for”
Deliver high-quality radiotherapy and cancer care to patients across Europe.
AMETHYST
VALUES
VALUES
“who we are; what we value;
how we behave together”
Amethyst’s values:
PATIENT FIRST
We care for our patients passionately. We design personalised treatments and deliver integrative cancer care. We strive to offer the best possible patient experience.
GOOD TEAMMATES, GOOD PARTNERS
Our network is our strength. As a team, we count on each other. We share best practices and learn from each other.
We build long-term partnerships with doctors, hospitals, authorities, payers, suppliers and NGOs (non-governmental organisations).
QUALITY & INTEGRITY
We do what’s best for our patients and our company, with no compromise on quality and safety. We are trustworthy and reliable. We communicate openly and authentically.
PERFORMANCE
We are a decentralised organisation. We take initiative and give our best. We lead by example and focus on results. We develop our people. We improve continuously.
Today’s profits are tomorrow’s investments.
INNOVATION
We work in a fast-changing, technology-intensive field. We embrace challenges and take calculated risks. We use state-of-the-art, proven technologies. We invest in research to stay at the forefront of radiotherapy.
DIVERSITY
We come from many countries and backgrounds. We respect each other, focus on what is best in each of us and cherish our differences.
History
2010
Foundation of Amethyst Radiotherapy, by Ludovic Robert and the Goldenberg family, who have been active in the healthcare and pharma markets in Europe for the past 35 years.
Discover
(sept)
2012
First Amethyst clinic becomes operational in Bucharest (Romania)
(dec)
2013
Opening of the first Amethyst radiotherapy center in Poland, located in Krakow.
(sept)
2014
Our second Amethyst clinic in Romania – located in Cluj – becomes operational
Discover
(sept)
2014
First Amethyst Centers in France : Compiègne and Creil clinics join Amethyst network of radiotherapy centers
(july)
2015
Amethyst welcomes a third clinic in France, located in La Garenne-Colombes, close to Paris and La Défense business district
(sept)
2016
Gray radiotherapy center in Maubeuge joins Amethyst and becomes the fourth Amethyst center in France
Discover
(may)
2017
First Amethyst radiotherapy center in Italy is established through a partnership with the Fatebenefratelli Order in Rome and is located on the Tiber Island.
2016
2017
2018
2019
Construction of new bunker in La Garenne-Colombes - equipped with a new Varian Truebeam linac - and investment in new Saginova equipment for brachytherapy
Extension of the Compiègne clinic, equipped with state-of-the-art equipment, including a Varian Trubeam linac
2017
2019
Major upgrade investment at Maubeuge clinic (installation of new Elektra Versa HD accelerator, scanner upgrade and new Raysearch TPS software)
Autumn
2019
Upgrade of Creil equipment (new Varian Truebeam linac and Exactrac position control system)
(nov)
2019
The Rohatyn Group invests in Amethyst Radiotherapy to accelerate the growth of the Company across Europe through the roll-up of clinics, the development of greenfield centers and outsourcing partnerships with hospitals.
Discover
(march)
2020
Amethyst Radiotherapy expands its footprint into the UK through the acquisition of Medical Equipment Solutions Limited (MESL), a specialised provider of intracranial radiation treatments at Queen Square Radiosurgery Center in London and Thornbury Radiosurgery Center in Sheffield.
(april)
2020
Third linear accelerator installed in Bucharest clinic, giving the center the capacity to treat 240 radiotherapy patients each day.
Discover
(may)
2020
Opening of Wien (Vienna) radiotherapy center